A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China

ObjectiveIn China, lung cancer ranks first in both incidence and mortality among all malignant tumors. Non-small cell lung cancer (NSCLC) constitutes the vast majority of cases, accounting for 80% to 85% of cases. Immune checkpoint inhibitors (ICIs), either as monotherapies or combined with other tr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hongmei Li, Yuliang Yuan, Qianjie Xu, Guangzhong Liang, Zuhai Hu, Xiaosheng Li, Wei Zhang, Haike Lei
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-11-01
coleção:	Frontiers in Immunology
Assuntos:	NSCLC PD-1/PD-L1 ICIS nomogram prognosis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1487078/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!